SCHEMBL6985377

SCHEMBL6985377

N#Cc1ccc(CCC(=O)N2CCCc3cc(NC(=O)c4ccccc4)ccc32)cc1

nearest known ligand 0.62

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
RAB9A P51151 2/20 0.62
TP53 P04637 4/20 0.55
LMNA P02545 3/20 0.55
ALDH1A1 P00352 1/20 0.51
MAPT P10636 2/20 0.49
POLB P06746 2/20 0.49
NR3C1 P04150 1/20 0.49
AR P10275 1/20 0.49
F2 P00734 1/20 0.47
PLG P00747 1/20 0.47
PLAU P00749 1/20 0.47
KLKB1 P03952 1/20 0.47
PRSS1 P07477 1/20 0.47
NPC1 O15118 1/20 0.47
GAA P10253 1/20 0.47
NFKB1 P19838 1/20 0.47
HTT P42858 1/20 0.47
NFKB2 Q00653 1/20 0.47
RELA Q04206 1/20 0.47
SMN1; SMN2 Q16637 1/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6986003 0.90 RAB9A (0.48) RAB9ATP53ALDH1A1MAPTNR3C1
SCHEMBL6984783 0.89 RAB9A (0.64) RAB9ATP53LMNAALDH1A1MAPT
SCHEMBL6986809 0.88 RAB9A (0.51) RAB9ATP53LMNAALDH1A1POLB
SCHEMBL6977738 0.88 TP53 (0.51) RAB9ATP53ALDH1A1MAPTPOLB
SCHEMBL6981983 0.87 RAB9A (0.46) RAB9ATP53LMNAALDH1A1MAPT
SCHEMBL6976631 0.86 HSD17B3 (0.46) RAB9ATP53ALDH1A1MAPTNR3C1
Hydrochloric Acid SCHEMBL6984868 0.85 RAB9A (0.60) RAB9ATP53LMNAALDH1A1MAPT
SCHEMBL6977395 0.85 TP53 (0.46) RAB9ATP53LMNAALDH1A1MAPT
SCHEMBL6986432 0.84 TP53 (0.48) RAB9ATP53ALDH1A1MAPTNR3C1
SCHEMBL6984459 0.84 FPR1 (0.44) RAB9ATP53LMNAALDH1A1NR3C1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0991624-B1 PHENYLALKYL DERIVATIVES WITH THROMBIN-INHIBITING EFFECT BOEHRINGER INGELHEIM PHARMA (DE) 2003-11-19 EP disclosed
US-6300342-B1 FOR THERAPY OR INHIBITING THROMBUS FORMATION; FOR THERAPY OF FIBRIN-DEPENDENT INFLAMMATORY CONDITION BOEHRINGER INGELHEIM PHARM KG (DE) 2001-10-09 US disclosed
EP-0991624-A1 PHENYLALKYL DERIVATIVES WITH THROMBIN-INHIBITING EFFECT Boehringer Ingelheim Pharma KG (DE) 2000-04-12 EP disclosed
WO-1999000371-A1 PHENYLALKYL DERIVATIVES WITH THROMBIN-INHIBITING EFFECT BOEHRINGER INGELHEIM PHARMA KG (DE) 1999-01-07 WO disclosed